Question 1

What is LOPJLB’s current signal on NGEN?

Accepted Answer

LOPJLB’s latest quantitative signal on NervGen Pharma Corp. Common stock (NGEN) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is NGEN in?

Accepted Answer

NervGen Pharma Corp. Common stock (NGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does NervGen Pharma Corp. Common stock (NGEN) do?

Accepted Answer

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer…

Question 4

Where is NervGen Pharma Corp. Common stock based / listed?

Accepted Answer

NervGen Pharma Corp. Common stock is based in CA, listed on NASDAQ.

NervGen Pharma Corp. (NGEN)

Key stats

Prediction markets

Company news